Mallinckrodt plc (NYSE:MNK): The stock had negative money flow to the tune of ($2.12 million) on Wednesday, which shows that the traders are selling the stock on the price strength. The inflow of money on upticks was $7.74 million, whereas, the outflow of money on downticks was $9.86 million and the ratio between the two was 0.79. The block trade had a negative net money flow of ($1.51 million). The total block trade value undertaken on upticks was $0.6 million. On the other hand, downticks amounted to $2.11 million of the traded value, which shows distribution in the stock by traders. The ratio between uptick and downtick was 0.28. Mallinckrodt plc (NYSE:MNK) closed with marginal gains of 312 cents to end the day at $59.35, an increase of 5.55% over the previous days close. The stock recorded 6.04% for the week.
In an insider trading activity, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the CFO of Mallinckrodt Plc, Harbaugh Matthew K, had purchased 500 shares in a transaction dated on May 10, 2016. The transaction was executed at $59.37 per share with total amount equaling $29,685. Currently the company Insiders own 0.53% of Mallinckrodt plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 1.5% . Institutional Investors own 97.89% of Mallinckrodt plc shares. During last six month period, the net percent change held by insiders has seen a change of 3.83%.
The company shares have dropped -53.25% from its 1 Year high price. On Jul 23, 2015, the shares registered one year high at $127.00 and the one year low was seen on Mar 16, 2016. The 50-Day Moving Average price is $60.21 and the 200 Day Moving Average price is recorded at $63.59. Mallinckrodt plc (NYSE:MNK): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $57.03 and $56.95 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $60.53. The buying momentum continued till the end and the stock did not give up its gains. It closed at $59.90, notching a gain of 6.53% for the day. The total traded volume was 1,802,030 . The stock had closed at $56.23 on the previous day.
Mallinckrodt public limited company (Mallinckrodt) is a global specialty pharmaceuticals company. The Company develops, manufactures, markets and distributes both branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API) and diagnostic imaging agents. The Company uses its API products in the manufacture of its generic pharmaceuticals and also sells them to other pharmaceutical companies. The Company operates through two segments: Specialty Pharmaceuticals and Global Medical Imaging. The Companys Specialty Pharmaceuticals segment develops, manufactures and sells, through its Brands business, drugs, including EXALGO (hydromorphone HCl) Extended-Release Tablets and GABLOFEN. The Companys Global Medical Imaging segment develops, manufactures and markets contrast media and delivery systems (CMDS). The Company offers INOMAX Total Care (inhaled nitric oxide), a neonatal critical care product.